ClinicalTrials.Veeva

Menu

A Study on a New Staining Method (C4d Staining) of Transplanted Kidney Biopsies

H

Hospital Authority, Hong Kong

Status

Completed

Conditions

Kidney Transplantation
Graft Rejection

Treatments

Procedure: Renal biopsy

Study type

Observational

Funder types

Other

Identifiers

NCT00498095
HARECCTR0500061
KW/EX/06-054

Details and patient eligibility

About

Patients who had received kidney transplantation may suffer from rejection. Recently, positive staining for C4d in kidney biopsies of malfunctioning transplant kidney is increasingly recognized as an important prognostic indicator of poorer long-term kidney outcome. Data is, however, lacking in Hong Kong.

Enrollment

52 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All renal allograft biopsies performed in Princess Margaret Hospital (PMH) during the period 1st April 2003 to 31st August 2005 for unexplained acute renal dysfunction (Creatinine rise from baseline by ≥ 20%) or delayed graft function in the immediate post-transplantation period were included in the study. Both cadaveric and living-donor transplant allografts were included.

Exclusion criteria

  • patients who were < 18 years' old at the time of renal biopsy or whose records were so incomplete that preclude meaningful analysis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems